GAA
EW icon

Global Assets Advisory’s Edwards Lifesciences EW Stock Holding History

Global Assets Advisory’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-309
Closed -$33.1K – 283
2025
Q2 		$33.1K Buy
+309
New +$23K 0.01% 219
2024
Q2 		– Sell
-31,951
Closed -$339K – 201
2024
Q1 		$339K Buy
+31,951
New +$2.68M 0.02% 385

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Global Assets Advisory's EW Position: Q3 2025 in Review

Global Assets Advisory sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 309 shares — an estimated $33.1K sold.

Global Assets Advisory first reported a position in EW in Q1 2024 and held it in 2 quarters. The position peaked at $339K in Q1 2024. 1,253 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • Global Assets Advisory reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
  • Global Assets Advisory sold 309 Edwards Lifesciences shares in Q3 2025, an estimated $33.1K.
  • Global Assets Advisory first reported a position in Edwards Lifesciences in Q1 2024 and held it in 2 quarters.
  • Global Assets Advisory's Edwards Lifesciences position peaked at $339K in Q1 2024.
  • 1,253 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Global Assets Advisory's 13F filing for Q3 2025, filed 31 Oct 2025.